Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS Read more
Novartis drug Afinitor DISPERZ receives FDA approval to treat TSC-associated partial-onset seizures Read more
Accelovance and Linical merge organizations to form a best-in-class CRO with increased global reach Read more
Proteostasis’ triple combination program secures FDA fast track designation for cystic fibrosis Read more
Dr. Reddy’s Laboratories and Promius Pharma announce the filing of an NDA for its migraine candidate Read more